This document contains abstracts from the Brazilian Journal of Pharmaceutical Sciences that summarize research related to adverse drug reactions associated with various medications. The abstracts cover topics such as the adverse reactions reported for new oral anticoagulants, the risk of atrioventricular block associated with the first dose of fingolimod, and the importance of MRI-based diagnosis of progressive multifocal leukoencephalopathy associated with natalizumab in asymptomatic cases. Other abstracts discuss risks of pancreatitis, tuberculosis, and various psychological and neurological adverse reactions associated with therapies targeting TNF-alpha, serotonin, GLP-1, and other substances.

1. Abstracts presented at scientific congresses and published:
NEW ORAL ANTICOAGULANTS: WHAT DO THEIR ADVERSE DRUG REACTIONS
REPORTS SUGGEST?
Drug Safety, 2015 Vol.38 Nº10, (PP 847-1048) - Abstracts 15th
ISoP Annual Meeting
ATRIOVENTRICULAR BLOCK ASSOCIATED WITH THE FIRST DOSE OF
FINGOLIMOD
Brazilian Journal Of Pharmaceutical Sciences Vol 50 – Suppl. 1 2014 pag 39
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATY ASSOCIATED TO
NATALIZUMAB: THE IMPORTANCE OF MRI BASED DIAGNOSIS IN
ASYMPYOMATIC CASES.
Brazilian Journal Of Pharmaceutical Sciences Vol 50 – Suppl. 1 2014 pag 39
RISK OF PANCREATITIS AND PANCREATIC CANCER ASSOCIATED WITH THERAPY
BASED ON INCRETINS
Brazilian Journal Of Pharmaceutical Sciences Vol 50 – Suppl. 1 2014 pag 28
ASSESSMENT OF SAFETY AND EFFECTIVITY ASSOCIATED TO OSELTAMIVIR
THERAPY
Brazilian Journal Of Pharmaceutical Sciences Vol 50 – Suppl. 1 2014 pag 33
RISK OF TUBERCULOSIS ASSOCIATED WITH THERAPY BASED ON INHIBITORS OF
TNF-ALPHA.
Brazilian Journal Of Pharmaceutical Sciences Vol 50 – Suppl. 1 2014 pag 33
ANALYSIS OF PSYCHOLOGICAL ADVERSE REACTIONS PROFILE OF THE
SELECTIVE INIBITORS OF THE RECAPTATION OF SEROTONIN (SIRS)
Brazilian Journal Of Pharmaceutical Sciences Vol 49 – Suppl. 1 2013 pag 13
ADVERSE DRUG REACTIONS OF LIRAGLUTIDE AND EXENATIDE: AN OVERVIEW IN
PHARMACOVIGILANCE.
Brazilian Journal Of Pharmaceutical Sciences Vol 48 – Suppl. 1 2012 pag 26
NATALIZUMAB ASSOCIATED TO PROGRESSIVE MULTIFOCAL
LEUKOENCEPHALOPATHY: PROPOSAL TO ESTABLISH A RISK MINIMIZATION PLAN.
Brazilian Journal Of Pharmaceutical Sciences Vol 48 – Suppl. 1 2012 pag 27
OSTEONECROSIS OF JAW IN USE OF BISPHOSPHONATES.
Brazilian Journal Of Pharmaceutical Sciences Vol 48 – Suppl. 1 2012 pag 99
RITUXIMAB AND HEMATOLOGICAL ADVERSE DRUG REACTION IN PATIENTS WITH
RHEUMATOID ARTHRITIS.
Brazilian Journal Of Pharmaceutical Sciences Vol 48 – Suppl. 1 2012 pag 27
ADVERSE DRUG REACTIONS RELATED TO USE OF INTERFERON BETA-1A,
INTERFERON BETA-1B AND GLATIRAMER FOR MULTIPLE SCLEROSIS TREATMENT.
Brazilian Journal Of Pharmaceutical Sciences Vol 48 – Suppl. 1 2012 pag 5
STUDY OF DRUG ADVERSE EFFECTS OF LEVONORGESTREL INTRAUTERINE
DEVICE.
Brazilian Journal Of Pharmaceutical Sciences Vol 47 – Suppl. 1 2011 pag 28

2. RITUXIMAB AND TOCILIZUMAB: COMPARISON OF PROFILES OF ADVERSE DRUG
REACTION.
Brazilian Journal Of Pharmaceutical Sciences Vol 47 – Suppl. 1 2011 pag 32
ISOTRETIOIN USE ASSOCIATION WITH TERATOGENIC EFFECT AND PSYCHIATRIC
DISORDERS: NEED TO IMPROVE RISK MANAGEMENT.
Brazilian Journal Of Pharmaceutical Sciences Vol 47 – Suppl. 1 2011 pag 34
INSULIN GLARGINE AND CANCER INCIDENCE.
Brazilian Journal Of Pharmaceutical Sciences Vol 47 – Suppl. 1 2011 pag 38
RISK OF NEUROPSYCHIATRIC ADVERSE DRUG REACTION ASSOCIATED TO USE
OF VARENICLINE TARTRATE.
Brazilian Journal Of Pharmaceutical Sciences Vol 47 – Suppl. 1 2011 pag 40
ANALYSIS OF ADVERSE DRUG REACTION PROFILEOF IMMUNOBIOLOGICAL TNF-
Α INHIBITORS: A PHARMACOVIGILANCE OVERVIEW.
Brazilian Journal Of Pharmaceutical Sciences Vol 47 – Suppl. 1 2011 pag 65